Next report date
Report period
Q1 2024
EPS estimate
−0.12USD
Revenue estimate
2.82 MUSD
−30.40 MUSD
7.04 MUSD
51.89 M
Om ProQR Therapeutics N.V.
Sektor
Bransch
VD
Daniel Anton de Boer
Webbplats
Huvudkvarter
Leiden
Employees (FY)
156
Grundat
2012
ISIN
NL0010872495
FIGI
BBG006N8B830
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
